PolicyET Techabout 1 hour ago
India Eases Drug Study Rules for Faster Generic Launches
3 min read
India's government will allow pharmaceutical companies to start eligible bioavailability and bioequivalence studies after informing the drug regulator, removing the prior permission requirement. This aims to speed up the launch of generic drugs in the local market.
Level
Hype check
Tap to vote and see what everyone thinks.